Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Fireman B.V. (IFRX)

Fireman B.V. (IFRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.9240 +0.0240 (+2.67%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.9240 unch (unch) 16:00 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.8736
Day High
0.9589
Open 0.8900
Previous Close 0.9000 0.9000
Volume 174,400 174,400
Avg Vol 381,885 381,885
Stochastic %K 15.83% 15.83%
Weighted Alpha -57.52 -57.52
5-Day Change -0.0860 (-8.51%) -0.0860 (-8.51%)
52-Week Range 0.8238 - 2.8150 0.8238 - 2.8150
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 62,031
  • Shares Outstanding, K 67,133
  • Annual Sales, $ 180 K
  • Annual Income, $ -49,850 K
  • EBIT $ -61 M
  • EBITDA $ -61 M
  • 60-Month Beta 2.21
  • Price/Sales 337.54
  • Price/Cash Flow N/A
  • Price/Book 0.80
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.08
  • Most Recent Earnings $-0.09 on 03/20/25
  • Next Earnings Date 05/14/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.18
  • Number of Estimates 3
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +5.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8238 +12.16%
on 04/09/25
Period Open: 1.1800
1.4200 -34.93%
on 03/24/25
-0.2560 (-21.69%)
since 03/11/25
3-Month
0.8238 +12.16%
on 04/09/25
Period Open: 2.2300
2.7700 -66.64%
on 02/13/25
-1.3060 (-58.57%)
since 01/10/25
52-Week
0.8238 +12.16%
on 04/09/25
Period Open: 1.5400
2.8150 -67.18%
on 12/06/24
-0.6160 (-40.00%)
since 04/11/24

Most Recent Stories

More News
Infinitum: Pioneering Quantum-Proof Blockchain Solutions to Transform Finance

The revolutionary blockchain ecosystem from Infinitum, powered by Lusis-global leader in financial systems-sets a new standard in security, resilience, and interoperability, bridging traditional and decentralized...

IFRX : 0.9240 (+2.67%)
InflaRx N.V. Receives Positive CHMP Opinion for Marketing Authorization of GOHIBIC for COVID-19 Linked Acute Respiratory Distress Syndrome Treatment

The CHMP recommends marketing authorization for InflaRx's GOHIBIC to treat COVID-19 related ARDS in certain patients.Quiver AI SummaryInflaRx N.V. announced that the Committee for Medicinal Products for...

IFRX : 0.9240 (+2.67%)
WuXi Biologics Announces Manufacturing Partnership with InflaRx to Advance Gohibic for the Treatment of Certain Critically Ill COVID-19 patients

/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced the...

IFRX : 0.9240 (+2.67%)
Stock Index Futures Move Higher Ahead of U.S. Inflation Data, Fed Minutes

June S&P 500 futures (ESM23) are up +0.28%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.21% this morning after three major U.S. benchmark indices finished the regular session mixed as market participants...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
CAT : 293.45 (+1.48%)
VOLVB.S.DX : 241.700 (+0.46%)
HTCR : 0.6600 (+4.76%)
HZON : 11.33 (+0.09%)
CFLT : 21.51 (+1.37%)
IFRX : 0.9240 (+2.67%)
MDB : 162.24 (+0.71%)
Why InflaRx Stock Skyrocketed This Week

The biopharmaceutical company's near-term sales outlook has gotten a huge boost following Emergency Use Authorization for one of its drugs.

RJF : 135.33 (+2.34%)
IFRX : 0.9240 (+2.67%)
Why Shares of InflaRx Are Soaring Wednesday

A key EUA from the FDA for the company's COVID-19 therapy gave the stock a jolt.

IFRX : 0.9240 (+2.67%)
Stock Index Futures Move Lower as Recession Fears Weigh on Sentiment

June S&P 500 futures (ESM23) are down -0.22%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.23% this morning after three major U.S. benchmark indices finished the regular session lower as a swathe...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
CAT : 293.45 (+1.48%)
JPM : 236.20 (+4.00%)
SW.FP : 55.750 (+1.09%)
KRUS : 49.26 (-3.24%)
IFRX : 0.9240 (+2.67%)
JNJ : 151.73 (+2.04%)
SGH : 20.85 (+0.43%)
BE : 17.64 (+4.69%)
CI : 330.19 (+0.89%)
InflaRx Reports Second Quarter 2022 Financial & Operating Results

Fast Track and Orphan Drug designation for vilobelimab in pyoderma gangrenosum (PG) granted by the FDAPlans to submit EUA with the FDA for vilobelimab in...

IFRX : 0.9240 (+2.67%)
InflaRx Announces Plans to Apply for Emergency Use Authorization from the US FDA for Vilobelimab for Treatment of Critically Ill COVID-19 Patients

Completed encouraging Type B meeting with US FDAApplication for EUA planned to be submitted in Q3 2022 JENA, Germany, July 26, 2022 (GLOBE NEWSWIRE) --...

IFRX : 0.9240 (+2.67%)
InflaRx Receives FDA Fast Track Designation for Treatment of Ulcerative Pyoderma Gangrenosum

US Food and Drug Administration awards Fast Track designation for the treatment of ulcerative pyoderma gangrenosumFast track follows recently reported...

IFRX : 0.9240 (+2.67%)

Business Summary

InflaRx N.V. is a clinical-stage biopharmaceutical company. It focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. InflaRx N.V. is based in Germany.

See More

Key Turning Points

3rd Resistance Point 1.0494
2nd Resistance Point 1.0041
1st Resistance Point 0.9641
Last Price 0.9240
1st Support Level 0.8788
2nd Support Level 0.8335
3rd Support Level 0.7935

See More

52-Week High 2.8150
Fibonacci 61.8% 2.0544
Fibonacci 50% 1.8194
Fibonacci 38.2% 1.5844
Last Price 0.9240
52-Week Low 0.8238

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar